Evaluation of Pathological Response in Post-Neoadjuvant Chemotherapy Breast Carcinoma Specimens using Residual Cancer Burden System
Introduction: Many systems have been proposed to classify the degree of tumour response to therapy in post-neoadjuvant Chemotherapy (NACT) breast cancers. The Residual Cancer Burden (RCB) developed by MD Anderson cancer hospital is an online tool for the quantification of residual disease that i...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2021-05-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://www.jcdr.net/articles/PDF/14917/48102_CE[Ra1]_F[SK]_PF1(MG_SHU)_PFA(MG_KM)%20GC(AnK)_PN(KM).pdf |